Abstract
Purpose
Muscarinic acetylcholine receptors (mAChRs) play an important role in the generation of seizures. Single-photon emission computed tomography (SPECT) with 123I-iododexetimide (IDEX) depicts tracer uptake by mAChRs. Our aims were to: (a) determine the optimum time for interictal IDEX SPECT imaging; (b) determine the accuracy of IDEX scans in the localisation of seizure foci when compared with video EEG and MR imaging in patients with temporal lobe epilepsy (TLE); (c) characterise the distribution of IDEX binding in the temporal lobes and (d) compare IDEX SPECT and 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in identifying seizure foci.
Methods
We performed sequential scans using IDEX SPECT imaging at 0, 3, 6 and 24 h in 12 consecutive patients with refractory TLE undergoing assessment for epilepsy surgery. Visual and region of interest analyses of the mesial, lateral and polar regions of the temporal lobes were used to compare IDEX SPECT, FDG PET and MR imaging in seizure onset localisation.
Results
The 6-h IDEX scan (92%; κ=0.83, p=0.003) was superior to the 0-h (36%; κ=0.01, p>0.05), 3-h (55%; κ=0.13, p>0.05) and 24-h IDEX scans in identifying the temporal lobe of seizure origin. The 6-h IDEX scan correctly predicted the temporal lobe of seizure origin in two patients who required intracranial EEG recordings to define the seizure onset. Reduced ligand binding was most marked at the temporal pole and mesial temporal structures. IDEX SPECT was superior to interictal FDG PET (75%; κ=0.66, p=0.023) in seizure onset localisation. MR imaging was non-localising in two patients in whom it was normal and in another patient in whom there was bilateral symmetrical hippocampal atrophy.
Conclusion
The 6-h IDEX SPECT scan is a viable alternative to FDG PET imaging in seizure onset localisation in TLE.
Similar content being viewed by others
References
McNamara JO. Selective alterations of regional beta-adrenergic receptor binding in the kindling model of epilepsy. Exp Neurol 1978;61(3):582–91.
Cavalheiro EA. The pilocarpine model of epilepsy. Ital J Neurol Sci 1995;16(1–2):33–7.
Cruickshank JW, Brudzynski SM, McLachlan RS. Involvement of M1 muscarinic receptors in the initiation of cholinergically induced epileptic seizures in the rat brain. Brain Res 1994;643(1–2):125–9.
Dasheiff RM, Savage DD, McNamara JO. Seizures down-regulate muscarinic cholinergic receptors in hippocampal formation. Brain Res 1982;235(2):327–34.
Danober L, Depaulis A, Marescaux C, Vergnes M. Effects of cholinergic drugs on genetic absence seizures in rats. Eur J Pharmacol 1993;234(2–3):263–8.
Dickson CT, Alonso A. Muscarinic induction of synchronous population activity in the entorhinal cortex. J Neurosci 1997;17(17):6729–44.
Hamilton SE, Loose MD, Qi M, Levey AI, Hille B, McKnight GS, et al. Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc Natl Acad Sci U S A 1997;94(24):13311–6.
Laird HE II, Hadjiconstantinou M, Neff NH. Abnormalities in the central cholinergic transmitter system of the genetically epilepsy-prone rat. Life Sci 1986;39(9):783–7.
Morrisett RA, Jope RS, Snead OC 3rd. Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats. Exp Neurol 1987;97(1):193–200.
Green RC, Blume HW, Kupferschmid SB, Mesulam MM. Alterations of hippocampal acetylcholinesterase in human temporal lobe epilepsy. Ann Neurol 1989;26(3):347–51.
Kish SJ, Olivier A, Dubeau F, Robitaille Y, Sherwin AL. Increased activity of choline acetyl transferase and acetylcholinesterase in actively epileptic human cerebral cortex. Epilepsy Res 1988;2:227–31.
Muller-Gartner HW, Wilson AA, Dannals RF, Wagner HNJ, Frost JJ. Imaging muscarinic cholinergic receptors in human brain in vivo with Spect, [123I]4-iododexetimide, and [123I]4-iodolevetimide. J Cereb Blood Flow Metab 1992;12(4):562–70.
Boundy KL, Rowe CC, Black AB, Kitchener MI, Barnden LR, Sebben R, et al. Localization of temporal lobe epileptic foci with iodine-123 iododexetimide cholinergic neuroreceptor single-photon emission computed tomography. Neurology 1996;47(4):1015–20.
Hooper PK, Meikle SR, Eberl S, Fulham MJ. Validation of post injection; transmission measurements for attenuation correction in neurologic FDG PET studies. J Nucl Med 1996;37:128–36.
Eberl S, Anayat AR, Fulton RR, Hooper PK, Fulham MJ. Evaluation of two population-based input functions for quantitative FDG PET studies. Eur J Nucl Med 1997;24:299–304.
Wilson AA, Dannals RF, Ravert HT, Frost JJ, Wagner HNJ. Synthesis and biological evaluation of [125I] and [123I]-4-iododexetimide, a potent muscarinic cholinergic receptor antagonist. J Med Chem 1989;32:1057–62.
Kassiou M, Mardon K, Katsifis AG, Najdovski L, Dikic B, Mattner F, et al. Radiosynthesis of [123I]N-methyl-4-iododexetimide and [123I]N-methyl-4-iodolevetimide: in vitro and in vivo characterisation of binding to muscarinic receptors in the rat heart. Nucl Med Biol 1996;23(2):147–53.
Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging 1994;13:601–9.
Meikle SR, Hutton BF, Bailey DL. A transmission-dependent method for scatter correction in SPECT. J Nucl Med 1994;35:360–7.
Eberl S, Kanno I, Fulton R, Ryan A, Hutton BF, Fulham MJ. Automated interstudy image registration technique for SPECT and PET. J Nucl Med 1996;37:137–45.
Ardekani BA, Braun M, Hutton BF, Kanno I, Iida H. A fully automatic multimodality image registration algorithm. J Comput Assist Tomogr 1995;19:615–23.
Bronen RA, Cheung G. Relationship of hippocampus and amygdala to coronal MRI landmarks. J Magn Reson Imaging 1991;9(3):449–57.
Boundy KL, Barnden LR, Rowe CC, Reid M, Kassiou M, Katsifis AG, Lambrecht RM. Human dosimetry and biodistribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors. J Nucl Med 1995;36(7):1332–8.
Newton MR, Berkovic SF, Austin MC, Rowe CC, McKay WJ, Bladin PF. Ictal postictal and interictal single-photon emission tomography in the lateralization of temporal lobe epilepsy. Eur J Nucl Med 1994;21(10):1067–71.
Muller-Gartner HW, Mayberg HS, Fisher RS, Lesser RP, Wilson AA, Ravert HT, et al. Decreased hippocampal muscarinic cholinergic receptor binding measured by 123I-iododexetimide and single-photon emission computed tomography in epilepsy. Ann Neurol 1993;34(2):235–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mohamed, A., Eberl, S., Fulham, M.J. et al. Sequential 123I-iododexetimide scans in temporal lobe epilepsy: comparison with neuroimaging scans (MR imaging and 18F-FDG PET imaging). Eur J Nucl Med Mol Imaging 32, 180–185 (2005). https://doi.org/10.1007/s00259-004-1654-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-004-1654-2